2.0
Jun 13, 2024
Recommend
CEO approval
Business Outlook
Pros
development, procedures, growth opportunities, many projects, hybrid model
Cons
manipulation, nepotism, gaslighting, no yearly bonuses, invigilation
61% would recommend to a friend
Charl van Zyl
72% approve of CEO
40% positive business outlook
Check out your Company Bowl for anonymous work chats.
The top reviewed jobs include
Users say... "its great for modern culture" "Many have left but many great people remain" "good benefits compared to some companies" "Honest, transparent structure with great colleagues" "Good salary and benefits"
Users say... "The managers are clueless here." "Senior management is changing and centralizing many things in HQ In Europe" "Bonus are average compared to other Pharmaceutical companies." "Lack opportunities to promote." "Ego got in between the upper management here and the 'international corporate managers'."